Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.640 | 5.360 | 0.720 |
Stocks | 95.370 | 95.370 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.615 | 19.906 |
Price to Book | 2.391 | 2.707 |
Price to Sales | 1.455 | 1.821 |
Price to Cash Flow | 10.898 | 13.684 |
Dividend Yield | 1.322 | 1.832 |
5 Years Earnings Growth | 11.037 | 12.493 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 37.180 | 14.245 |
Industrials | 22.270 | 36.890 |
Technology | 11.770 | 14.352 |
Consumer Defensive | 9.520 | 5.584 |
Real Estate | 8.140 | 11.502 |
Communication Services | 6.170 | 5.297 |
Basic Materials | 1.820 | 4.872 |
Financial Services | 1.750 | 5.943 |
Consumer Cyclical | 1.380 | 7.705 |
Number of long holdings: 37
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AAK | SE0011337708 | 6.33 | 316.0 | +0.32% | |
Ambea | SE0009663826 | 6.07 | 97.15 | -0.10% | |
MedCap | SE0009160872 | 5.52 | 598.000 | +0.67% | |
Vimian Group AB | SE0015961982 | 4.51 | 42.10 | +2.06% | |
Lagercrantz B | SE0014990966 | 4.48 | 211.20 | +0.96% | |
Fastighets AB Balder B | SE0017832488 | 4.45 | 76.16 | +1.76% | |
Addtech | SE0014781795 | 4.32 | 303.00 | +0.13% | |
Bufab Holding AB | SE0005677135 | 4.26 | 434.80 | -0.23% | |
Xvivo Perfusion AB | SE0004840718 | 3.96 | 466.50 | +1.08% | |
Tobii Dynavox AB | SE0017105620 | 3.91 | 56.50 | -0.53% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Evli Global B SEK | 3.19B | 16.84 | 13.87 | 12.97 | ||
Evli Sweden Equity Index B | 2.71B | 7.59 | 6.46 | 8.58 | ||
Evli Swedish Small Cap A | 1.5B | 5.84 | -9.86 | 12.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review